{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:02:19Z","timestamp":1793253739151,"version":"4.5.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The HIV epidemic in Africa is characterized by extensive viral subtype diversity and human genetic heterogeneity which influence disease outcomes; amidst the co-morbidities that modulate HIV reservoirs and immune responses. This paper provides an overview of the quantity and spectrum of HIV cure research in context of the contributions made by African scientists toward HIV cure related research in Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a hybrid environmental scan, we searched the Treatment Action Group website to identify registered HIV cure-related observational and interventional studies between 1995-2024. To identify published papers related to HIV or SIV latency, we searched PubMed for articles with HIV or SIV in the title PLUS terms related to virus latency in the title or in medical subject headings (MeSH); and downloaded results in PubMed format in a text file. We used an R script which checked NCBI to identify articles which cited the original paper that first described the HIV reservoir in 1995, restricting to only those within the query result. This was repeated using loop functions until we obtained all articles directly or indirectly linked to the original paper.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, we show an increasing trend of HIV cure-related observational and interventional studies globally; with the least number of studies in Africa. The PubMed query retrieved 7122 HIV cure-related published articles, as at 23 July 2024; of which 2820 were directly or indirectly linked to understanding the HIV reservoir. Of the 2916 articles with first author affiliation country determined, only 52 (0.02%) had affiliations from African institutions. Of the 1955 articles with last author affiliation country determined, only 43 (0.02%) had affiliations from institutions in Africa. The majority of articles with first or last authors from African institutes were descriptive clinical studies of HIV infection, with less than ten studies specifically addressing HIV latency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Scale up of HIV cure research in Africa remains critical to hasten achievement of the global goal of an end to the AIDS epidemic by 2030. There is a need to bridge the technical, infrastructural and technological divides and address constraints in funding and capacity; to promote discovery, characterization and application of promising innovative therapies including immunotherapies and cell and gene therapies towards attaining an effective, durable, affordable and scalable HIV cure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1576667","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:28:07Z","timestamp":1754630887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["HIV cure research contributions from Africa in the last three decades"],"prefix":"10.3389","volume":"16","author":[{"given":"Damalie","family":"Nakanjako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward N.","family":"Kankaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Galiwango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokameh","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thumbi","family":"Ndung\u2019u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","volume-title":"Fact Sheet 2024: Global HIV statistics","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-022-00587-3","article-title":"Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda","volume":"19","author":"Joussef-Pina","year":"2022","journal-title":"Retrovirology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00815.x","article-title":"Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts","volume":"115","author":"Messele","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.025","article-title":"Genetic ancestry and natural selection drive population differences in immune responses to pathogens","volume":"167","author":"Nedelec","year":"2016","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199611000-00012","article-title":"Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals","volume":"10","author":"Rizzardini","year":"1996","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.862270","article-title":"Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies","volume":"13","author":"Ta","year":"2022","journal-title":"Front Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1745-6215-15-57","article-title":"HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial","volume":"15","author":"Hayes","year":"2014","journal-title":"Trials"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2006.25.223","article-title":"Are viral-encoded microRNAs mediating latent HIV-1 infection","volume":"25","author":"Weinberg","year":"2006","journal-title":"DNA Cell Biol"},{"key":"B9","volume-title":"Global HIV Statistics","year":"2022"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00396-2","article-title":"HIV and women in the USA: what we know and where to go from here","volume":"397","author":"Adimora","year":"2021","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139287","article-title":"Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda","volume":"5","author":"Prodger","year":"2020","journal-title":"JCI Insight"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv219","article-title":"The remarkable stability of the latent reservoir for HIV-1 in resting memory CD4+ T cells","volume":"212","author":"Siliciano","year":"2015","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41419-019-1661-7","article-title":"Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00236-9","article-title":"HIV-1 reservoir size after neonatal antiretroviral therapy and the potential tof evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1\/2 proof-of-concept study","volume":"11","author":"Persaud","year":"2024","journal-title":"Lancet HIV"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12865-021-00450-8","article-title":"Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort","volume":"22","author":"Nabatanzi","year":"2021","journal-title":"BMC Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz320","article-title":"Monocyte dysfunction, activation, and inflammation after long-term antiretroviral therapy in an African cohort","volume":"220","author":"Nabatanzi","year":"2019","journal-title":"J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2019.02.010","article-title":"Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort","volume":"201","author":"Nabatanzi","year":"2019","journal-title":"Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad539","article-title":"Increased levels of caspase-1 and IL-1beta among adults with persistent immune activation after 12 years of suppressive antiretroviral therapy in the infectious diseases institute HIV treatment cohort","volume":"10","author":"Nabatanzi","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e31910","DOI":"10.1016\/j.heliyon.2024.e31910","article-title":"Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort","volume":"10","author":"Nakanjako","year":"2024","journal-title":"Heliyon"},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-11-43","article-title":"High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort","volume":"11","author":"Nakanjako","year":"2011","journal-title":"BMC Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"111126","DOI":"10.1016\/j.celrep.2022.111126","article-title":"Immune correlates of HIV-1 reservoir cell decline in early-treated infants","volume":"40","author":"Hartana","year":"2022","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau0528","article-title":"Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection","volume":"11","author":"Ndhlovu","year":"2019","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153046","article-title":"IFN-alpha blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health","volume":"7","author":"Swainson","year":"2022","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886562","article-title":"Role of early life cytotoxic T lymphocyte and natural killer cell immunity in paediatric HIV cure\/remission in the anti-retroviral therapy era","volume":"13","author":"Vieira","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.08.006","article-title":"Targeted immune interventions for an HIV-1 cure","volume":"23","author":"Perreau","year":"2017","journal-title":"Trends Mol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/v12010084","article-title":"Block-and-lock strategies to cure HIV infection","volume":"12","author":"Vansant","year":"2020","journal-title":"Viruses"},{"key":"B28","article-title":"Towards an HIV cure","volume-title":"Research Priorities for an HIV Cure: IAS Global Scientific Strategy 2021: The science in context","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat Med"},{"key":"B30","volume-title":"Research toward a cure trials","year":"2024"},{"key":"B31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12961-017-0196-6","article-title":"A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences","volume":"15","author":"Nakanjako","year":"2017","journal-title":"Health Res Policy Syst"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12688\/aasopenres","article-title":"Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University - Uganda Virus Research Institute research and training programme","volume":"3","author":"Nakanjako","year":"2020","journal-title":"AAS Open Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12879-014-0680-3","article-title":"In vitroreactivation of latent HIV-1 by cytostatic bis(thiosemicarbazonate) gold(III) complexes","volume":"14","author":"Fonteh","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00277-15","article-title":"Lentivector knockdown of CCR5 in hematopoietic stem and progenitor cells confers functional and persistent HIV-1 resistance in humanized mice","volume":"89","author":"Myburgh","year":"2015","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.202","article-title":"Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex","volume":"24","author":"Saayman","year":"2016","journal-title":"Mol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.192","article-title":"CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice","volume":"24","author":"Xu","year":"2016","journal-title":"Mol Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd8179","article-title":"Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption","volume":"13","author":"Gondim","year":"2021","journal-title":"Sci Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/s41598-020-59596-x","article-title":"In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha","volume":"10","author":"Ashokkumar","year":"2020","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005154","article-title":"Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-alpha resistance","volume":"11","author":"Deymier","year":"2015","journal-title":"PloS Pathog"},{"key":"B40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1742-4690-10-146","article-title":"Relative resistance of HIV-1 founder viruses to control by interferon-alpha","volume":"10","author":"Fenton-May","year":"2013","journal-title":"Retrovirology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620144114","article-title":"Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness","volume":"114","author":"Iyer","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38130","DOI":"10.1038\/srep38130","article-title":"Transmission of Multiple HIV-1 Subtype C Transmitted\/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/v16040609","article-title":"Mechanisms of hepatitis B virus cccDNA and minichromosome formation and HBV gene transcription","volume":"16","author":"Gomez-Moreno","year":"2024","journal-title":"Viruses"},{"key":"B44","article-title":"HIV\/AIDS: Framework for action in the WHO African region, 2016-2030","volume-title":"End HIV\/AIDS by 2030","year":"2017"},{"key":"B45","volume-title":"Translating Opportunity to Reality: How We Can End AIDS by 2030","year":"2024"},{"key":"B46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5334\/aogh.3214","article-title":"Building and sustaining effective partnerships for training the next generation of global health leaders","volume":"87","author":"Nakanjako","year":"2021","journal-title":"Ann Glob Health"},{"key":"B47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12961-023-01056-9","article-title":"How to improve research capacity strengthening efforts: learning from the monitoring and evaluation of four research consortia in Africa","volume":"21","author":"Kasprowicz","year":"2023","journal-title":"Health Res Policy Syst"},{"key":"B48","volume-title":"Supporting HIV cure researchers in Africa","author":"Africure","year":"2024"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix478","article-title":"Reduced frequency of cells latently infected with replication-competent human immunodeficiency virus-1 in virally suppressed individuals living in Rakai, Uganda","volume":"65","author":"Prodger","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1038\/s41467-024-48985-9","article-title":"HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy","volume":"15","author":"Lee","year":"2024","journal-title":"Nat Commun"},{"key":"B51","volume-title":"Fighting HIV, TB and Malaria: the Foundation for Healthy, Productive Lives for Everyone","year":"2024"},{"key":"B52","year":""},{"key":"B53","year":"2015"},{"key":"B54","volume-title":"Africa Europe Clusters of Excellence","year":"2023"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czae030","article-title":"Unfair knowledge practices in global health: a realist synthesis","volume":"39","author":"Abimbola","year":"2024","journal-title":"Health Policy Plan"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-008950","article-title":"How to identify epistemic injustice in global health research funding practices: a decolonial guide","volume":"7","author":"Koum Besson","year":"2022","journal-title":"BMJ Glob Health"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1576667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T08:30:13Z","timestamp":1758184213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1576667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2025.1576667"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1576667","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1576667"}}